"T-Lymphocytes" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen.
| Descriptor ID |
D013601
|
| MeSH Number(s) |
A11.118.637.555.567.569 A15.145.229.637.555.567.569 A15.382.490.555.567.569
|
| Concept/Terms |
T-Lymphocytes- T-Lymphocytes
- T Lymphocytes
- T-Lymphocyte
- T-Cells
- T Cells
- T-Cell
- Thymus-Dependent Lymphocytes
- Lymphocyte, Thymus-Dependent
- Lymphocytes, Thymus-Dependent
- Thymus Dependent Lymphocytes
- Thymus-Dependent Lymphocyte
|
Below are MeSH descriptors whose meaning is more general than "T-Lymphocytes".
Below are MeSH descriptors whose meaning is more specific than "T-Lymphocytes".
This graph shows the total number of publications written about "T-Lymphocytes" by people in this website by year, and whether "T-Lymphocytes" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 7 | 3 | 10 |
| 1997 | 8 | 3 | 11 |
| 1998 | 13 | 4 | 17 |
| 1999 | 4 | 6 | 10 |
| 2000 | 9 | 5 | 14 |
| 2001 | 7 | 5 | 12 |
| 2002 | 11 | 18 | 29 |
| 2003 | 12 | 17 | 29 |
| 2004 | 12 | 12 | 24 |
| 2005 | 18 | 12 | 30 |
| 2006 | 18 | 12 | 30 |
| 2007 | 18 | 20 | 38 |
| 2008 | 18 | 15 | 33 |
| 2009 | 18 | 9 | 27 |
| 2010 | 18 | 13 | 31 |
| 2011 | 18 | 15 | 33 |
| 2012 | 14 | 13 | 27 |
| 2013 | 18 | 12 | 30 |
| 2014 | 19 | 4 | 23 |
| 2015 | 24 | 9 | 33 |
| 2016 | 19 | 14 | 33 |
| 2017 | 29 | 19 | 48 |
| 2018 | 28 | 13 | 41 |
| 2019 | 23 | 7 | 30 |
| 2020 | 28 | 13 | 41 |
| 2021 | 23 | 20 | 43 |
| 2022 | 4 | 25 | 29 |
| 2023 | 6 | 33 | 39 |
| 2024 | 13 | 19 | 32 |
| 2025 | 14 | 9 | 23 |
| 2026 | 3 | 2 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "T-Lymphocytes" by people in Profiles.
-
Enhancing CAR- and TCR-mediated targeting of cancer via an immune synapse-stabilizing receptor. Nat Commun. 2026 Feb 04; 17(1):1349.
-
Tumor-specific immune responses and biomarkers in pediatric patients with high-risk Hodgkin lymphoma. Blood Adv. 2026 Jan 13; 10(1):183-191.
-
To the nines: IL-9 boosts T cell function. Immunity. 2026 Jan 13; 59(1):14-16.
-
Human Progenitor T-Cell Differentiation Regulated by the Mechanical Resistance of Thymus-Mimetic Extracellular Matrices. Adv Healthc Mater. 2026 Mar; 15(12):e04316.
-
Autologous multiantigen-targeted T cell therapy for pancreatic cancer: a phase 1/2 trial. Nat Med. 2026 Jan; 32(1):258-269.
-
International consensus guidelines for the conduct and reporting of CAR T-cell clinical trials in AML. Blood Adv. 2025 Dec 09; 9(23):6047-6058.
-
Personalized CRISPR knock-in cytokine gene therapy to remodel the tumor microenvironment and enhance CAR T cell therapy in solid tumors. Nat Commun. 2025 Dec 09; 16(1):10987.
-
Tunneling CARs: Increasing CAR T-Cell Tumor Infiltration through the Overexpression of MMP-7 and Osteopontin-b. Cancer Immunol Res. 2025 Nov 03; 13(11):1732-1748.
-
Single cell RNA-seq analysis of hematopoietic cell types in 22q11.2 deletion syndrome reveals significant changes to non-T cells. Pediatr Allergy Immunol. 2025 11; 36(11):e70237.
-
Tumor Intrinsic METTL5 Modulates ATF4 Translation to Prevent T Cell-Induced Ferroptosis in Ovarian Cancer. Adv Sci (Weinh). 2025 Dec; 12(46):e07718.